▎Editor of WuXi AppTec content team

Mallinckrodt recently announced that the US FDA has approved the listing

Hepatorenal syndrome is an acute, life-threatening condition

Terlipressin is a synthetic analogue of vasopressin, but this drug is about 2 times more selective for vasopressin V1 receptors than V2 receptors

Molecular structure of terlipressin (Credit: Edgar181, Public domain, via Wikimedia Commons)

The FDA approval is based in part on the results

The most common adverse reactions in the drug group compared with placebo (≥4%) included abdominal pain (drug group: 19.

Dr Steven Romano, Executive Vice President and Chief Scientific Officer of Mallinckrodt, said: "Diagnosing and treating HCS can be quite challenging, and caring for patients in this category is critical every minute

WuXi AppTec provides integrated, end-to-end new drug development and manufacturing services to the global biopharmaceutical industry, covering the fields

▲If you have any business needs, please long press to scan the QR code above, or